Skip to Main Content

Author Details

Fengshen Kuo
Memorial Sloan Kettering Cancer Center
2003
53
24
PMIDPaper TitleJournal TitlePublished Year
37864521Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.Cancer2024
36780190Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy.Clin Cancer Res2023
37529400Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities.Cancer Res Commun2023
37620627Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.Nat Med2023
37501404Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.Mol Oncol2023
37419120Patterns of immune equilibrium and escape in indolent and progressing tumors.Cancer Cell2023
37185232Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma.J Immunother Cancer2023
37413991Immunometabolic coevolution defines unique microenvironmental niches in ccRCC.Cell Metab2023
37337120A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation.Nat Metab2023
36927002Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade.J Clin Oncol2023
34725502Improved prediction of immune checkpoint blockade efficacy across multiple cancer types.Nat Biotechnol2022
35705800Author Correction: Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies.Nat Immunol2022
35731870Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma.Sci Adv2022
35758895A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.Cancer Discov2022
35817971Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity.Nat Genet2022
35565392Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma.Cancers (Basel)2022
35618834Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies.Nat Immunol2022
36536472Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape.Genome Med2022
36564410Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
36044718Immune Checkpoint Blockade Outcome in Small-Cell Lung Cancer and Its Relationship With Retinoblastoma Mutation Status and Function.JCO Precis Oncol2022
36323682FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
36288724Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer.Immunity2022
36190538Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade.Clin Cancer Res2022
34789562Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity.Mol Cancer Ther2022
34635506Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy.Mol Cancer Res2022
33318038Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival.Cancer Res2021
33861994Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy.Cancer Cell2021
33834176Mutations in <i>BRCA1</i> and <i>BRCA2</i> differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy.Nat Cancer2021
34524864Ectopic activation of the miR-200c-EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy.Sci Transl Med2021
34156736Genetic variation in catechol-O-methyltransferase is associated with individual differences in conditioned pain modulation in healthy subjects.J Gene Med2021
34284719Pre-capture multiplexing provides additional power to detect copy number variation in exome sequencing.BMC Bioinformatics2021
33429428Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial.J Natl Cancer Inst2021
32220885Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression.Clin Cancer Res2020
31870811Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.Lancet Oncol2020
33087928TGF-β suppresses type 2 immunity to cancer.Nature2020
32820162A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response.Nat Commun2020
32324171Commensal bacteria stimulate antitumor responses via T cell cross-reactivity.JCI Insight2020
30622105Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial.Cancer Discov2019
31700181Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy.Nat Med2019
31640776Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.J Immunother Cancer2019
31422205APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.Oral Oncol2019
31011208Immunogenic neoantigens derived from gene fusions stimulate T cell responses.Nat Med2019
31048490Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.Science2019
29217585Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.Science2018
30107176Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.Cancer Cell2018
30416077Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.Lancet Oncol2018
29659925Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas.J Natl Cancer Inst2018
29033130Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.Cell2017
29084941Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions.Nat Commun2017
25726343Interleukin 1 genetic tests provide no support for reduction of preventive dental care.J Am Dent Assoc2015
  • 1 - 50 of 53

Recommended Authors

Reanne Bowlby
Career Start Year 2015
Number of shared co-authors 7
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 1
David C Qian
Winship Cancer Institute of Emory University
Career Start Year 2015
Number of shared co-authors 0
Reyka G Jayasinghe
Washington University in St Louis
Career Start Year 2015
Number of shared co-authors 4
Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Ankur Chakravarthy
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 3
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 9
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 2
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 14
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 5
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 0
Samuel S Freeman
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 1
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 2
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 2
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 3
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 4
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 5
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 15
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 13
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 7
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 14
Charles Swanton
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 11
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 2
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Aaron M Newman
Stanford University
Career Start Year 1994
Number of shared co-authors 1
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 4

Collaborators

Timothy A Chan
Cleveland Clinic.
Co-authored papers 32
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Co-authored papers 22
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Co-authored papers 20
Abraham Ari Hakimi
Co-authored papers 18
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Co-authored papers 14
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Alan L Ho
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Nora Katabi
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Richard J Wong
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Michael F Berger
Co-authored papers 3
Xin Pei
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Li Liu
College of Big Data & Software Engineering, Chongqing University
Co-authored papers 3
Nicholas D Socci
Co-authored papers 3
Niels Weinhold
Co-authored papers 3
Christina S Leslie
Co-authored papers 3
James J Hsieh
Washington University
Co-authored papers 3
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 2
Anuradha Gopalan
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Raakhee Vijayaraghavan
Co-authored papers 2
David G Pfister
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Miriam Donaldson
Co-authored papers 2
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Co-authored papers 2
Benjamin D Greenbaum
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Mauro A A Castro
Federal University of Parana
Co-authored papers 2
Daniel W Kelly
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Michael T Boyce-Jacino
Institute of Human Genetics, University of Minnesota
Co-authored papers 2
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 2
Sahussapont J Sirintrapun
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Mark Lee
Memorial Sloan Kettering Cancer Center (MSKCC)
Co-authored papers 2
Release 1.2